---
title: "SBFM Q1'26 Earnings: EPS estimate is (0.16) USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286085312.md"
description: "SBFM (Sunshine Biopharma Inc.) is set to announce its Q1'26 results on May 13, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q1'26, revenue estimate is 9.20 million USD with EPS (earnings per share) anticipated at (0.16) USD. Learn more details at .Revenue & EPS values are provided in USDQ1'25Q2'25Q3'25Q4'25Q1'26Revenue Reported8.90 M9.41 M9.42 M8.58 M—Revenue Estimate—11.20 M11.10 M10.00 M9.20 MRevenue Surprise-15.98%-15.16%-14.23%EPS Reported(0.44)(0.39)(0.19)(0.30) EPS Estimate(0.11)(0.13)(0.27)(0.16) EPS Surprise-254.55%-46.15%-11.11%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc."
datetime: "2026-05-12T11:00:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286085312.md)
  - [en](https://longbridge.com/en/news/286085312.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286085312.md)
---

# SBFM Q1'26 Earnings: EPS estimate is (0.16) USD

SBFM (Sunshine Biopharma Inc.) is set to announce its Q1'26 results on May 13, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q1'26, revenue estimate is 9.20 million USD with EPS (earnings per share) anticipated at (0.16) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

Q1'25

Q2'25

Q3'25

Q4'25

Q1'26

**Revenue Reported**

8.90 M

9.41 M

9.42 M

8.58 M

—

**Revenue Estimate**

—

11.20 M

11.10 M

10.00 M

9.20 M

**Revenue Surprise**

\-15.98%

\-15.16%

\-14.23%

**EPS Reported**

(0.44)

(0.39)

(0.19)

(0.30)

**EPS Estimate**

(0.11)

(0.13)

(0.27)

(0.16)

**EPS Surprise**

\-254.55%

\-46.15%

\-11.11%

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [SBFM.US](https://longbridge.com/en/quote/SBFM.US.md)
- [SBFMW.US](https://longbridge.com/en/quote/SBFMW.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [Legend Biotech Q1 Solid for Carvykti, Focus Shifts to In Vivo Pipeline, RBC Says](https://longbridge.com/en/news/286290495.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)
- [Praxis Highlights FDA NDA Acceptances and Strengthened Cash Runway](https://longbridge.com/en/news/286322553.md)
- [Shah Capital Management Will Vote ‘No' Across Five Proposals On Novavax's June 18 Ballot - SEC Filing](https://longbridge.com/en/news/286565204.md)